| 1. |
- Garte, S, et al.
(författare)
-
Metabolic gene polymorphism frequencies in control populations
- 2001
-
Ingår i: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. - 1055-9965. ; 10:12, s. 1239-1248
-
Tidskriftsartikel (refereegranskat)
|
|
| 2. |
- Smits, KM, et al.
(författare)
-
Association of metabolic gene polymorphisms with tobacco consumption in healthy controls
- 2004
-
Ingår i: International Journal of Cancer. - : Wiley. - 0020-7136 .- 1097-0215. ; 110:2, s. 266-270
-
Tidskriftsartikel (refereegranskat)abstract
- Polymorphisms in genes that encode for metabolic enzymes have been associated with variations in enzyme activity between individuals. Such variations could be associated with differences in individual exposure to carcinogens that are metabolized by these genes. In this study, we examine the association between polymorphisms in several metabolic genes and the consumption of tobacco in a large sample of healthy individuals. The database of the International Collaborative Study on Genetic Susceptibility to Environmental Carcinogens was used. All the individuals who were controls from the case-control studies included in the data set with information on smoking habits and on genetic polymorphisms were selected (n = 20,938). Sufficient information was available on the following genes that are involved in the metabolism of tobacco smoke constituents: CYPIAI, GSTMI, GSTTI, NAT2 and GSTPI. None of the tested genes was clearly associated with smoking behavior. Information on smoking dose, available for a subset of subjects, showed no effect of metabolic gene polymorphisms on the amount of smoking. No association between polymorphisms in the genes studied and tobacco consumption was observed; therefore, no effect of these genes on smoking behavior should be expected.
|
|
| 3. |
- Benhamou, S, et al.
(författare)
-
Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk
- 2002
-
Ingår i: Carcinogenesis. - : Oxford University Press (OUP). - 0143-3334 .- 1460-2180. ; 23:8, s. 1343-1350
-
Tidskriftsartikel (refereegranskat)abstract
- Susceptibility to lung cancer may in part be attributable to inter-individual variability in metabolic activation or detoxification of tobacco carcinogens. The glutathione S-transferase M1 (GSTM1) genetic polymorphism has been extensively studied in this context; two recent meta-analyses of case-control studies suggested an association between GSTM1 deletion and lung cancer. At least 15 studies have been published after these overviews. We undertook a new meta-analysis to summarize the results of 43 published case-control studies including >18 000 individuals. A slight excess of risk of lung cancer for individuals with the GSTM1 null genotype was found (odds ratio (OR) = 1.17, 95% confidence interval (CI) 1.07-1.27). No evidence of publication bias was found (P = 0.4), however, it is not easy to estimate the extent of such bias and we cannot rule out some degree of publication bias in our results. A pooled analysis of the original data of about 9500 subjects involved in 21 case-control studies from the International Collaborative Study on Genetic Susceptibility to Environmental Carcinogens (GSEC) data set was performed to assess the role of GSTM1 genotype as a modifier of the effect of smoking on lung cancer risk with adequate power. Analyses revealed no evidence of increased risk of lung cancer among carriers of the GSTM1 null genotype (age-, gender- and center-adjusted OR = 1.08, 95% CI 0.98-1.18) and no evidence of interaction between GSTM1 genotype and either smoking status or cumulative tobacco consumption.
|
|
| 4. |
|
|
| 5. |
- Beral, V, et al.
(författare)
-
Alcohol, tobacco and breast cancer - collaborative reanalysis of individual data from 53 epidemiological studies, including 58515 women with breast cancer and 95067 women without the disease
- 2002
-
Ingår i: British Journal of Cancer. - : Springer Science and Business Media LLC. - 1532-1827 .- 0007-0920. ; 87, s. 1234-45
-
Tidskriftsartikel (refereegranskat)abstract
- Alcohol and tobacco consumption are closely correlated and published results on their association with breast cancer have not always allowed adequately for confounding between these exposures. Over 80% of the relevant information worldwide on alcohol and tobacco consumption and breast cancer were collated, checked and analysed centrally. Analyses included 58515 women with invasive breast cancer and 95067 controls from 53 studies. Relative risks of breast cancer were estimated, after stratifying by study, age, parity and, where appropriate, women's age when their first child was born and consumption of alcohol and tobacco. The average consumption of alcohol reported by controls from developed countries was 6.0 g per day, i.e. about half a unit/drink of alcohol per day, and was greater in ever-smokers than never-smokers, (8.4 g per day and 5.0 g per day, respectively). Compared with women who reported drinking no alcohol, the relative risk of breast cancer was 1.32 (1.19 - 1.45, P < 0.00001) for an intake of 35 - 44 g per day alcohol, and 1.46 (1.33 - 1.61, P < 0.00001) for greater than or equal to 45 g per day alcohol. The relative risk of breast cancer increased by 7.1% (95% CI 5.5-8.7%; P<0.00001) for each additional 10 g per day intake of alcohol, i.e. for each extra unit or drink of alcohol consumed on a daily basis. This increase was the same in ever-smokers and never-smokers (7.1 % per 10 g per day, P < 0.00001, in each group). By contrast, the relationship between smoking and breast cancer was substantially confounded by the effect of alcohol. When analyses were restricted to 22 255 women with breast cancer and 40 832 controls who reported drinking no alcohol, smoking was not associated with breast cancer (compared to never-smokers, relative risk for ever-smokers= 1.03, 95% CI 0.98 - 1.07, and for current smokers=0.99, 0.92 - 1.05). The results for alcohol and for tobacco did not vary substantially across studies, study designs, or according to 15 personal characteristics of the women; nor were the findings materially confounded by any of these factors. If the observed relationship for alcohol is causal, these results suggest that about 4% of the breast cancers in developed countries are attributable to alcohol. In developing countries, where alcohol consumption among controls averaged only 0.4 g per day, alcohol would have a negligible effect on the incidence of breast cancer. In conclusion, smoking has little or no independent effect on the risk of developing breast cancer; the effect of alcohol on breast cancer needs to be interpreted in the context of its beneficial effects, in moderation, on cardiovascular disease and its harmful effects on cirrhosis and cancers of the mouth, larynx, oesophagus and liver. (C) 2002 Cancer Research UK.
|
|
| 6. |
|
|
| 7. |
- Snell, James P, et al.
(författare)
-
Species specific isotope dilution calibration for determination of mercury species by gas chromatography coupled to inductively coupled plasma- or furnace atomisation plasma ionisation-mass spectrometry
- 2000
-
Ingår i: JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY. - : Royal Society of Chemistry (RSC). ; 15:12, s. 1540-5
-
Tidskriftsartikel (refereegranskat)abstract
- Standard solutions of(CH3)(2)Hg, CH3HgCl and HgCl2 were prepared in toluene from isotopically enriched mercury. Methods for synthesising (CH3)(2)Hg and CH3HgCl, from HgCl2, were developed with reaction yields of 95.2% and 92.7%. respectively, without noticeable loss of isotope. Isotopically enriched species standards were then used for species specific isotope dilution calibration and method assurance tests for mercury species determination. An interface was built to couple a gas chromatograph (GC) to an inductively coupled plasma mass spectrometer (ICP-MS) that resulted in rapid and efficient transfer of organic mercury compounds eluted from, natural gas condensates. Oxygen, introduced to the plasma auxiliary gas, reduced matrix interferences and improved sensitivity by a factor of two. The GC-ICP-MS method with species specific isotope dilution calibration gave recovery values of 97.7 +/- 2.0, 104.1 +/- 0.7 and 106.6 +/- 2.1% for (CH3)(2)Hg, CH3HgCl and HgCl2 respectively, in natural gas condensate compared to a standard solution of the species in toluene. Detection limits of the three species, calculated from 3s of the peak areas derived from 20 pg of the species (as Hg) in solution, were 8, 2 and 3 pg. Furnace atomisation plasma ionisation mass spectrometry (FAPIMS) was also evaluated as a detector with the GC methodology. When the plasma was operated with optimised conditions for the generation of elemental ions, recoveries were 100.0 +/- 2.9, 98.3 +/- 1.5 and 97.5 +/- 1.2% for (CH3)(2)Hg, CH3HgCl and HgCl2 in a 10% condensate solution, and a detection limit of 33 pg was obtained for methylmercury. A plasma was also generated and sustained with reduced rf power and graphite furnace temperature so that molecular ions and fragments were produced and detected by the same spectrometer, which demonstrated the potential of FAPIMS as a sensitive elemental detector additionally capable of providing molecular mass spectra for the identification of species eluted from a GC column.
|
|
| 8. |
|
|
| 9. |
- Stewart, W, et al.
(författare)
-
Non-traumatic forensic neuropathology.
- 2004
-
Ingår i: Forensic Sci Int. - 0379-0738. ; 146:2-3, s. 125-47
-
Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)
|
|
